CN104459115A - GP73 and PIVKA-II combined detection kit - Google Patents
GP73 and PIVKA-II combined detection kit Download PDFInfo
- Publication number
- CN104459115A CN104459115A CN201410735789.5A CN201410735789A CN104459115A CN 104459115 A CN104459115 A CN 104459115A CN 201410735789 A CN201410735789 A CN 201410735789A CN 104459115 A CN104459115 A CN 104459115A
- Authority
- CN
- China
- Prior art keywords
- pivka
- antibody
- vitamin
- antagonist
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 71
- 108010063628 acarboxyprothrombin Proteins 0.000 title claims abstract description 67
- 102100021184 Golgi membrane protein 1 Human genes 0.000 title claims abstract description 25
- 101001040742 Homo sapiens Golgi membrane protein 1 Proteins 0.000 title claims abstract description 24
- 238000012360 testing method Methods 0.000 claims abstract description 60
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 35
- 230000006698 induction Effects 0.000 claims abstract description 35
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 22
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 22
- 101800001271 Surface protein Proteins 0.000 claims abstract description 13
- 239000004005 microsphere Substances 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 claims description 54
- 206010047634 Vitamin K deficiency Diseases 0.000 claims description 54
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 claims description 54
- 239000010931 gold Substances 0.000 claims description 33
- 229910052737 gold Inorganic materials 0.000 claims description 33
- 239000012530 fluid Substances 0.000 claims description 27
- 238000013016 damping Methods 0.000 claims description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 19
- 239000000872 buffer Substances 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 12
- 241001494479 Pecora Species 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 2
- 239000008118 PEG 6000 Substances 0.000 claims description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 claims description 2
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 claims description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 229930003448 Vitamin K Natural products 0.000 abstract description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019168 vitamin K Nutrition 0.000 abstract description 3
- 239000011712 vitamin K Substances 0.000 abstract description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract description 3
- 229940046010 vitamin k Drugs 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 210000002288 golgi apparatus Anatomy 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 11
- 238000002203 pretreatment Methods 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 8
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 8
- 201000007270 liver cancer Diseases 0.000 description 8
- 208000014018 liver neoplasm Diseases 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- 101000860173 Myxococcus xanthus C-factor Proteins 0.000 description 6
- 229930091371 Fructose Natural products 0.000 description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 5
- 239000005715 Fructose Substances 0.000 description 5
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 5
- 229940037003 alum Drugs 0.000 description 5
- 239000001177 diphosphate Substances 0.000 description 5
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 5
- 235000011180 diphosphates Nutrition 0.000 description 5
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 5
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 5
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 5
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 5
- -1 alum Chemical compound 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 206010073069 Hepatic cancer Diseases 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 108050005430 Golgi membrane protein 1 Proteins 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101001040734 Homo sapiens Golgi phosphoprotein 3 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000011806 microball Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410735789.5A CN104459115B (en) | 2014-12-05 | 2014-12-05 | A kind of GP73, PIVKA-II combined detection kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410735789.5A CN104459115B (en) | 2014-12-05 | 2014-12-05 | A kind of GP73, PIVKA-II combined detection kit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104459115A true CN104459115A (en) | 2015-03-25 |
CN104459115B CN104459115B (en) | 2016-01-13 |
Family
ID=52905503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410735789.5A Active CN104459115B (en) | 2014-12-05 | 2014-12-05 | A kind of GP73, PIVKA-II combined detection kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104459115B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN102854324A (en) * | 2012-08-17 | 2013-01-02 | 西北大学 | Method for rapid nondestructive detection of liver tumor marker and test paper strip adopted by the method |
CN102879559A (en) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | Real-time quantitative detection reagent and method of time-resolved fluorescence immune chromatography |
CN103364550A (en) * | 2013-07-16 | 2013-10-23 | 天津大学 | Method and device for rapidly and quantitatively detecting tumor marker with immunochromatography test strip marked by quantum dots |
CN103529207A (en) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | Combined device for rapidly and quantitatively detecting multiple tumor markers |
-
2014
- 2014-12-05 CN CN201410735789.5A patent/CN104459115B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN102879559A (en) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | Real-time quantitative detection reagent and method of time-resolved fluorescence immune chromatography |
CN102854324A (en) * | 2012-08-17 | 2013-01-02 | 西北大学 | Method for rapid nondestructive detection of liver tumor marker and test paper strip adopted by the method |
CN103364550A (en) * | 2013-07-16 | 2013-10-23 | 天津大学 | Method and device for rapidly and quantitatively detecting tumor marker with immunochromatography test strip marked by quantum dots |
CN103529207A (en) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | Combined device for rapidly and quantitatively detecting multiple tumor markers |
Non-Patent Citations (1)
Title |
---|
KAI ZHU等: "biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy", 《BIOMARKER RESEARCH》, vol. 1, no. 10, 31 December 2013 (2013-12-31) * |
Also Published As
Publication number | Publication date |
---|---|
CN104459115B (en) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104360085B (en) | A kind of AFP detection kit | |
Musteata et al. | Bioanalytical applications of solid-phase microextraction | |
Chen et al. | Fast analysis of ketamine using a colorimetric immunosorbent assay on a paper-based analytical device | |
US20210063334A1 (en) | Apparatus and methods for detection of diabetes-associated molecules using electrochemical impedance spectroscopy | |
AU2003243558A1 (en) | Test strip for detection of analyte and methods of use | |
NO20001126D0 (en) | A non-invasive transdermal system for detecting analytes | |
WO2008040990A3 (en) | Methods for determining an analyte concentration using signal processing algorithms | |
El Hassani et al. | Development of a highly sensitive and selective molecularly imprinted electrochemical sensor for sulfaguanidine detection in honey samples | |
ATE472732T1 (en) | TESTING ANALYTES USING LATERAL MIGRATION IMMUNCHROMATOGRAPHY | |
CA2510377A1 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
CN104459138B (en) | A kind of IGFBP-1 detection kit | |
Ruiz-Vega et al. | Paper microfluidics on screen-printed electrodes for simple electrochemical magneto-immunosensor performance | |
CN104407155B (en) | A kind of AFP, GP73, PIVKA-II combined detection kit | |
CN104391122B (en) | A kind of AFP, PIVKA-II combined detection kit | |
CN104360080B (en) | A kind of golgiosome glycoprotein-73 detection kit | |
Martínez-Mancera et al. | Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum | |
Chen et al. | Electrochemical identification of hepatocellular carcinoma based on the assay of human cervical cancer oncoprotein-1 in serum | |
CN104360079B (en) | A kind of PIVKA-II detection kit | |
CN104360082B (en) | A kind of AFP, GP73 combined detection kit | |
CN104360071B (en) | The kit of content of glycocholic acid in a kind of Fast Measurement serum or blood plasma | |
CN104459115B (en) | A kind of GP73, PIVKA-II combined detection kit | |
HK1138643A1 (en) | Method for determining an analyte in a bodily fluid | |
CN104374911B (en) | A kind of detection by quantitative rheumatoid factor, the detection kit of antistreptolysin O (ASO) | |
CN104459140A (en) | Detection kit for quantitative detection of rheumatoid factor, antistreptolysin O, anti cyclic citrullinated peptide antibody and C reactive protein | |
CN104360083A (en) | Detection kit for quantitatively detecting rheumatoid factors and antistreptolysin O and C reactive proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160307 Address after: 200436, room 238, No. three, 406 Shanghai Road, Zhabei District, China Patentee after: Shanghai Rui Rui Biotechnology Co., Ltd. Address before: Jiulongpo Branch Park four street 400039 Chongqing city 70-1, 70-2 block J No. six Patentee before: CHONGQING QIANDE BIOTECHNOLOGY CO., LTD. |
|
CB03 | Change of inventor or designer information |
Inventor after: Ji Quan Inventor after: Wang Lianghua Inventor before: Chen Hengyu |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: 400000 Taikang Road Dadukou District of Chongqing Bridge Industrial Park C District No. 6 Building 30 layer 1-4 Patentee after: Chongqing Zhongyuan Ji Ji Biological Technology Co., Ltd. Address before: 200436, room 238, No. three, 406 Shanghai Road, Zhabei District, China Patentee before: Shanghai Rui Rui Biotechnology Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee after: Zhongyuan Huiji Biotechnology Co.,Ltd. Address before: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee before: CHONGQING ZHONGYUAN HUIJI BIOTECHNOLOGY Co.,Ltd. |